CVS HEALTH CORPORATION

CVS Health Corporation specializes in the manufacturing of pharmaceutical preparations, delivering precisely formulated medication dosages to meet strict federal requirements. Their technical expertise centers on tablet formulation, dosage consistency, and supply chain precision for controlled pharmaceutical products, ensuring compliance with Good Manufacturing Practices (GMP) and FDA regulatory standards. The company demonstrates a focused capability in producing multi-dose, daily-regimen pharmaceuticals, with demonstrated experience in fulfilling time-sensitive, high-integrity contracts requiring exact tabulation and batch accountability. Their operational differentiator lies in the ability to scale production of standardized, high-volume oral solid dosage forms while maintaining rigorous quality control protocols across the manufacturing lifecycle. The contractor has delivered pharmaceutical manufacturing services to the Department of Justice, indicating engagement in federal law enforcement or correctional healthcare programs where controlled medication distribution is critical. This relationship suggests alignment with institutional healthcare delivery systems requiring secure, auditable pharmaceutical supply chains for inmate populations or specialized federal personnel. Their primary industry focus is pharmaceutical preparation manufacturing (NAICS 325412), a niche within the broader pharmaceutical sector that emphasizes the production of finished dosage forms rather than active pharmaceutical ingredients. This vertical specialization positions them as a contract manufacturer for government entities requiring reliable, compliant, and traceable oral medication supply—particularly for institutional or custodial care settings. As a 2L entity headquartered in Woonsocket, Rhode Island, CVS Health Corporation operates as a large-scale corporate structure with established manufacturing infrastructure. While no government certifications are listed, their ability to secure federal pharmaceutical contracts implies adherence to federal quality and regulatory frameworks. Their geographic presence is anchored in the Northeast, with a market position centered on supplying regulated, high-volume pharmaceutical products to federal agencies with institutional healthcare mandates.